» Articles » PMID: 20484388

P63 and P73, the Ancestors of P53

Overview
Date 2010 May 21
PMID 20484388
Citations 198
Authors
Affiliations
Soon will be listed here.
Abstract

p73 and p63 are two homologs of the tumor suppressive transcription factor p53. Given the high degree of structural similarity shared by the p53 family members, p73 and p63 can bind and activate transcription from the majority of the p53-responsive promoters. Besides overlapping functions shared with p53 (i.e., induction of apoptosis in response to cellular stress), the existence of extensive structural variability within the family determines unique roles for p63 and p73. Their crucial and specific functions in controlling development and differentiation are well exemplified by the p63 and p73 knockout mouse phenotypes. Here, we describe the contribution of p63 and p73 to human pathology with emphasis on their roles in tumorigenesis and development.

Citing Articles

p63: A Master Regulator at the Crossroads Between Development, Senescence, Aging, and Cancer.

Sadu Murari L, Kunkel S, Shetty A, Bents A, Bhandary A, Rivera-Mulia J Cells. 2025; 14(1.

PMID: 39791744 PMC: 11719615. DOI: 10.3390/cells14010043.


TIP60 enhances cisplatin resistance via regulating ΔNp63α acetylation in SCC.

Hira A, Zhang J, Kadakia M Cell Death Dis. 2024; 15(12):877.

PMID: 39627186 PMC: 11615348. DOI: 10.1038/s41419-024-07265-6.


TAp73 and ΔTAp73 isoforms show cell-type specific distributions and alterations in cancer.

Hrabal V, Stenckova M, Zavadil Kokas F, Muller P, Nenutil R, Vojtesek B Sci Rep. 2024; 14(1):29949.

PMID: 39622910 PMC: 11612387. DOI: 10.1038/s41598-024-80927-9.


TAp73 regulates mitochondrial dynamics and multiciliated cell homeostasis through an OPA1 axis.

Buckley N, Craxton A, Sun X, Panatta E, Pinon L, Beier S Cell Death Dis. 2024; 15(11):807.

PMID: 39516459 PMC: 11549358. DOI: 10.1038/s41419-024-07130-6.


Decoding the immune landscape: a comprehensive analysis of immune-associated biomarkers in cervical carcinoma and their implications for immunotherapy strategies.

Wang L, Liu H, Feng Y, Liu X, Wang Y, Liu Y Front Genet. 2024; 15:1340569.

PMID: 38933923 PMC: 11199791. DOI: 10.3389/fgene.2024.1340569.


References
1.
Nakagawa T, Takahashi M, Ozaki T, Watanabe K, Hayashi S, Hosoda M . Negative autoregulation of p73 and p53 by DeltaNp73 in regulating differentiation and survival of human neuroblastoma cells. Cancer Lett. 2003; 197(1-2):105-9. DOI: 10.1016/s0304-3835(03)00090-9. View

2.
Melino G, Lu X, Gasco M, Crook T, Knight R . Functional regulation of p73 and p63: development and cancer. Trends Biochem Sci. 2003; 28(12):663-70. DOI: 10.1016/j.tibs.2003.10.004. View

3.
Ghioni P, DAlessandra Y, Mansueto G, Jaffray E, Hay R, La Mantia G . The protein stability and transcriptional activity of p63alpha are regulated by SUMO-1 conjugation. Cell Cycle. 2004; 4(1):183-90. DOI: 10.4161/cc.4.1.1359. View

4.
Mills A, Zheng B, Wang X, Vogel H, Roop D, Bradley A . p63 is a p53 homologue required for limb and epidermal morphogenesis. Nature. 1999; 398(6729):708-13. DOI: 10.1038/19531. View

5.
Stiewe T, Theseling C, Putzer B . Transactivation-deficient Delta TA-p73 inhibits p53 by direct competition for DNA binding: implications for tumorigenesis. J Biol Chem. 2002; 277(16):14177-85. DOI: 10.1074/jbc.M200480200. View